Trials / Completed
CompletedNCT02934789
Effectiveness of Truclear on Patient Quality of Life
Randomized Prospective Study of the Effectiveness of the Truclear Device for Hysteroscopic Myomectomy on Patient Quality of Life
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- All For Women Healthcare, Illinois · Academic / Other
- Sex
- Female
- Age
- 21 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study aims to evaluate the quality of life in patients treated for submucosal leiomyomas using the Truclear hysteroscopic morcellator compared to women managed medically. Study population includes women age 18 and older with symptomatic submucosal myomas. Patients will be asked to complete the Uterine Myoma Symptom and Health-related Quality of Life Questionnaire (UFS-QOL) at enrollment and at 1, 3, and 6 months after treatment.
Detailed description
Submucosal myomas are a common cause of pelvic complaints and abnormal uterine bleeding (AUB) and there are many available modalities for treatment. Hysteroscopic myomectomy is a minimally invasive approach for removal of submucosal leiomyomas. Alternatively, medical management can be attempted. This study aims to evaluate the quality of life in patients treated for submucosal leiomyomas using the Truclear hysteroscopic morcellator compared to women managed medically. Study population includes women age 18 and older with symptomatic submucosal myomas. Patients will be asked to complete the Uterine Myoma Symptom and Health-related Quality of Life Questionnaire (UFS-QOL) at enrollment and at 1, 3, and 6 months after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hysteroscopic myomectomy with Truclear | Hysteroscopic myomectomy with Truclear done on patients with abnormal uterine bleeding and submucosal fibroid(s). |
| DRUG | Medical therapy | Medical therapy for patients with abnormal uterine bleeding/ heavy menses and submucosal fibroids. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2018-04-01
- Completion
- 2018-05-01
- First posted
- 2016-10-17
- Last updated
- 2018-06-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02934789. Inclusion in this directory is not an endorsement.